Twareat Medical Care Company (TADAWUL:9627)

TADAWUL:9627 Income Statement

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Revenue	191.81	154.72	149.51
Revenue Growth (YoY)	23.97%	3.49%	-
Cost of Revenue	131.69	107.08	90.93
Gross Profit	60.12	47.65	58.57
Selling, General & Admin	32	28.53	25.18
Operating Expenses	34.88	31.84	31.7
Operating Income	25.24	15.81	26.87
Interest Expense	-0.64	-0.53	-0.65
Other Non Operating Income (Expenses)	0.3	0.23	0.64
EBT Excluding Unusual Items	24.9	15.52	26.87
Gain (Loss) on Sale of Assets	-	-	0.09
Pretax Income	24.9	15.52	26.96
Income Tax Expense	1.39	1.35	1.52
Net Income	23.51	14.17	25.43
Net Income to Common	23.51	14.17	25.43
Net Income Growth	65.98%	-44.30%	-
Shares Outstanding (Basic)	40	40	-
Shares Outstanding (Diluted)	40	40	-
EPS (Basic)	0.59	0.35	-
EPS (Diluted)	0.59	0.35	-
EPS Growth	65.98%	-	-
Free Cash Flow	2.54	1.48	18.54
Free Cash Flow Per Share	0.06	0.04	-
Dividend Per Share	0.250	0.240	1.600
Dividend Growth	4.17%	-85.00%	-
Gross Margin	31.34%	30.80%	39.18%
Operating Margin	13.16%	10.22%	17.97%
Profit Margin	12.26%	9.16%	17.01%
Free Cash Flow Margin	1.32%	0.95%	12.40%
EBITDA	28.54	18.13	28.23
EBITDA Margin	14.88%	11.72%	18.88%
D&A For EBITDA	3.3	2.32	1.36
EBIT	25.24	15.81	26.87
EBIT Margin	13.16%	10.22%	17.97%
Effective Tax Rate	5.57%	8.69%	5.65%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.